Explore our research

We're adopting a radical new approach to our research. We're speeding up the process of finding better treatments for Parkinson's, and delivering them to people faster.

Parkinson's didn't stop for coronavirus and neither did we. We're working hard to ensure that our research projects keep driving on in the search for new life-changing treatments.

Towards better treatments and care

As the largest charity funder of Parkinson's research in Europe, we've invested over £100 million in vital research that has delivered groundbreaking discoveries, new medications and better care. And right now new treatments are within our grasp.

We believe that together, we’ll find a cure

We’re a powerful global movement of scientists and supporters, investors and innovators. Driven by people with Parkinson’s every step of the way.

 

How we're speeding up the search for a cure

Investing in pioneering research

We're backing the best and brightest minds to unlock the ideas that will lead to new treatments, and one day a cure. Our research projects explore all aspects of Parkinson's, from genetics to gut bacteria, stem cells to sleep.

Accelerating drug discovery

We partner with organisations from around the globe to fast-track promising discoveries. Our pioneering research initiatives, like the Parkinson's Virtual Biotech, are filling the gaps and investing in big ideas to accelerate research and deliver better treatments to the people who need them, faster.

Changing the future of trials

We believe clinical trials can work better, so we’re bringing the right people together in a global collaboration to make trials faster, cheaper and more likely to succeed. With the Critical Path for Parkinson's, we can improve clinical trials and give new treatments the best chance of success.

Identifying drugs with hidden potential

We're taking the fastest route to better treatments by tracking down drugs already approved and in use for other conditions which have untapped potential for Parkinson's. This is called drug repurposing, and it could make new treatments available for people with Parkinson's much more quickly, easily and cheaply.